Patents by Inventor Alison J. Pilgrim

Alison J. Pilgrim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONTROLLED RELEASE COMPOSITIONS OF AGENTS THAT REDUCE CIRCULATING LEVELS OF PLATELETS AND METHODS THEREFOR
    Publication number: 20180153810
    Abstract: Provided are prophylactic and therapeutic methods of treatment of subjects for the purpose of inhibiting vaso-occlusive events, including embolism, by administering agents, including anagrelide and anagrelide derivatives, which reduce the number of circulating platelets to low normal or to below normal levels. Methods and pharmaceutical preparations comprising such agents are provided.
    Type: Application
    Filed: July 12, 2017
    Publication date: June 7, 2018
    Inventors: Paul F. GLIDDEN, Alison J. PILGRIM, Stephen R. HANSON
  • Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
    Patent number: 9750698
    Abstract: Provided are prophylactic and therapeutic methods of treatment of subjects for the purpose of inhibiting vaso-occlusive events, including embolism, by administering agents, including anagrelide and anagrelide derivatives, which reduce the number of circulating platelets to low normal or to below normal levels. Methods and pharmaceutical preparations comprising such agents are provided.
    Type: Grant
    Filed: May 31, 2016
    Date of Patent: September 5, 2017
    Assignee: BioVascular, Inc.
    Inventors: Paul F. Glidden, Alison J. Pilgrim, Stephen R. Hanson
  • CONTROLLED RELEASE COMPOSITIONS OF AGENTS THAT REDUCE CIRCULATING LEVELS OF PLATELETS AND METHODS THEREFOR
    Publication number: 20170112767
    Abstract: Provided are prophylactic and therapeutic methods of treatment of subjects for the purpose of inhibiting vaso-occlusive events, including embolism, by administering agents, including anagrelide and anagrelide derivatives, which reduce the number of circulating platelets to low normal or to below normal levels. Methods and pharmaceutical preparations comprising such agents are provided.
    Type: Application
    Filed: May 31, 2016
    Publication date: April 27, 2017
    Inventors: Paul F. GLIDDEN, Alison J. PILGRIM, Stephen R. HANSON
  • Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
    Patent number: 9381198
    Abstract: Provided are prophylactic and therapeutic methods of treatment of subjects for the purpose of inhibiting vaso-occlusive events, including embolism, by administering agents, including anagrelide and anagrelide derivatives, which reduce the number of circulating platelets to low normal or to below normal levels. Methods and pharmaceutical preparations comprising such agents are provided.
    Type: Grant
    Filed: March 27, 2015
    Date of Patent: July 5, 2016
    Assignee: BioVascular, Inc.
    Inventors: Paul F. Glidden, Alison J. Pilgrim, Stephen R. Hanson
  • CONTROLLED RELEASE COMPOSITIONS OF AGENTS THAT REDUCE CIRCULATING LEVELS OF PLATELETS AND METHODS THEREFOR
    Publication number: 20160051552
    Abstract: Provided are prophylactic and therapeutic methods of treatment of subjects for the purpose of inhibiting vaso-occlusive events, including embolism, by administering agents, including anagrelide and anagrelide derivatives, which reduce the number of circulating platelets to low normal or to below normal levels. Methods and pharmaceutical preparations comprising such agents are provided.
    Type: Application
    Filed: March 27, 2015
    Publication date: February 25, 2016
    Inventors: Paul F. GLIDDEN, Alison J. PILGRIM, Stephen R. HANSON
  • Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
    Patent number: 9040483
    Abstract: Provided are prophylactic and therapeutic methods of treatment of subjects for the purpose of inhibiting vaso-occlusive events, including embolism, by administering agents, including anagrelide and anagrelide derivatives, which reduce the number of circulating platelets to low normal or to below normal levels. Methods and pharmaceutical preparations comprising such agents are provided.
    Type: Grant
    Filed: July 17, 2012
    Date of Patent: May 26, 2015
    Assignee: BIOVASCULAR, INC.
    Inventors: Paul F. Glidden, Alison J. Pilgrim, Stephen R. Hanson
  • CONTROLLED RELEASE COMPOSITIONS OF AGENTS THAT REDUCE CIRCULATING LEVELS OF PLATELETS AND METHODS THEREFOR
    Publication number: 20130022671
    Abstract: Provided are prophylactic and therapeutic methods of treatment of subjects for the purpose of inhibiting vaso-occlusive events, including embolism, by administering agents, including anagrelide and anagrelide derivatives, which reduce the number of circulating platelets to low normal or to below normal levels. Methods and pharmaceutical preparations comprising such agents are provided.
    Type: Application
    Filed: July 17, 2012
    Publication date: January 24, 2013
    Inventors: Paul F. Glidden, Alison J. Pilgrim, Stephen R. Hanson
  • Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
    Publication number: 20090324710
    Abstract: Provided are prophylactic and therapeutic methods of treatment of subjects for the purpose of inhibiting vaso-occlusive events, including embolism, by administering agents, including anagrelide and anagrelide derivatives, which reduce the number of circulating platelets to low normal or to below normal levels. Methods and pharmaceutical preparations comprising such agents are provided.
    Type: Application
    Filed: June 16, 2009
    Publication date: December 31, 2009
    Inventors: Paul F. Glidden, Alison J. Pilgrim, Stephen R. Hanson
  • Method for treating tension type headaches or headaches associated with drugs or their withdrawal
    Patent number: 5376672
    Abstract: The present invention provides a new medical use for 3-[2-(dimethylamino)-ethyl]-N-methyl-1H-indole-5-methanesulphonamide and physiologically acceptable salts and solvates thereof in the treatment of tension-type headache and headache associated with substances or their withdrawal.
    Type: Grant
    Filed: April 6, 1993
    Date of Patent: December 27, 1994
    Assignee: Glaxo Group Limited
    Inventor: Alison J. Pilgrim